Literature DB >> 20844667

Tc99m MDP bone SPECT in a case of osteomyelitis of the skull.

Ravinder Singh Sethi1, Br Mittal, Anish Bhattacharya, Baljinder Singh.   

Abstract

A seven-year-old male child presented with swelling at the left temporal region. His skull X-ray was normal. A three-phase bone scan showed increased blood flow, soft tissue activity, and increased tracer concentration in the left temporal region. Single photon emission computed tomography (SPECT) imaging of the skull revealed full thickness involvement of the left temporal bone. Our case report shows that, in osteomyelitis of the skull, SPECT imaging provides significantly more information for identifying the extent and thickness of bone involvement.

Entities:  

Keywords:  99mTc-MDP; Bone SPECT; osteomyelitis skull

Year:  2010        PMID: 20844667      PMCID: PMC2934594          DOI: 10.4103/0972-3919.63597

Source DB:  PubMed          Journal:  Indian J Nucl Med        ISSN: 0974-0244


INTRODUCTION

We report a case where SPECT has shown an incremental value over conventional three phase Bone Scintigraphy in diagnosing osteomyelitis of skull

CASE REPORT

A seven-year-old male child presented with a swelling of two months' duration in the left temporal region. It was not associated with fever and there was no history of trauma. On examination, the swelling was 4 × 4 cm in size and hard in consistency. The skull X-ray was normal. Fine needle aspiration cytology (FNAC) was suggestive of inflammation. However, no response was noticed with broad spectrum antibiotics given for two weeks. Subsequently, a three-phase bone scan done with 99mTc-MDP (Methylene Diphosphonate) showed increased blood flow and soft tissue tracer concentration in the left temporal region. Delayed static images also showed increased tracer concentration in the left temporal region [Figure 1a]. However, to determine the full extent of bone involvement, a SPECT study of the skull was performed, which revealed increased tracer concentration in the left temporal region, involving full thickness of the bone [Figures 1b and c]. Finally a diagnosis of acute inflammatory process involving the left temporal region was made. Later curettage of the swelling was done and the subperiosteal pus collection was drained. Pus culture showed growth of Staphylococcus aureus. The patient responded to oral cloxacillin.
Figure 1

Left lateral view of the skull (a) of the Tc99m MDP static planar bone scan showing an oval area of increased tracer concentration in the left temporal region. Transverse section (b) and Sagittal view (c) of bone the SPECT of the skull showing the extent of the increased tracer concentration in the left temporal region involving full thickness of the bone

Left lateral view of the skull (a) of the Tc99m MDP static planar bone scan showing an oval area of increased tracer concentration in the left temporal region. Transverse section (b) and Sagittal view (c) of bone the SPECT of the skull showing the extent of the increased tracer concentration in the left temporal region involving full thickness of the bone

DISCUSSION

Acute osteomyelitis may be of hematogenous origin or may be caused by a direct wound or puncture. Hematogenous osteomyelitis is a relatively common problem in children. Early diagnosis and treatment frequently leads to complete recovery. Early diagnosis may be difficult, because conventional and radiological findings are often nonspecific, subtle or simply absent. Skeletal scintigraphy may establish an early diagnosis and thus lead to therapy before much bone destruction occurs. In a three-phase bone scan, initial hyperemia represents increased blood flow due to inflammation, while delayed bone images demonstrate increased radiotracer concentration.[12] Photopenic or cold patterns may also be seen in acute hematogenous osteomyelitis.[34] Acute hematogenous osteomyelitis most often involves rapidly growing bone and characteristically localizes in the metaphysis of long bones.[5] In children, the most common sites of osteomyelitis are the head of the femur, humerus head, ileum, ischium, talus, and patella.[4] Osteomyelitis of the skull as demonstrated in this case is an uncommon entity. The focus of infection being near the brain, the urgency in making this diagnosis and starting therapy is self-evident. This case shows how a three-phase bone scan along with the SPECT of the skull were helpful in making the diagnosis of osteomyelitis of the skull and in describing the extent of bone involvement. Skull SPECT is a good adjunctive technique to the three-phase bone scan in such cases.
  4 in total

1.  Diagnosis of osteomyelitis in children by combined blood pool and bone imaging.

Authors:  D L Gilday; D J Paul; J Paterson
Journal:  Radiology       Date:  1975-11       Impact factor: 11.105

2.  "Cold spots" in pediatric bone imaging.

Authors:  M Rosovsky; C R Goldfarb; H Finestone; F Ongseng
Journal:  Semin Nucl Med       Date:  1994-04       Impact factor: 4.446

3.  Extensive photopenic osteomyelitis.

Authors:  P K Rehm; A D Aaron
Journal:  J Nucl Med       Date:  1996-10       Impact factor: 10.057

4.  The gamut of increased whole bone activity in bone scintigraphy in children.

Authors:  C M Glasier; J J Seibert; S L Williamson
Journal:  Clin Nucl Med       Date:  1987-03       Impact factor: 7.794

  4 in total
  2 in total

1.  Effects of bone cement filling in rabbit proximal femoral medullary cavity on distal femoral blood flow and metabolism.

Authors:  Li-Cheng Xi; Hong-Yu Li; Ming Zhang; Si-Cheng Huang
Journal:  J Int Med Res       Date:  2018-10-14       Impact factor: 1.573

2.  Evaluation of deoxyribonucleic acid toxicity induced by the radiopharmaceutical 99mTechnetium-Methylenediphosphonic acid and by stannous chloride in Wistar rats.

Authors:  José Carlos Pelielo De Mattos; Vanessa Coutinho de Matos; Michelle Pinheiro Rodrigues; Marcia Betânia Nunes de Oliveira; Flavio José S Dantas; Sebastião David Santos-Filho; Mario Bernardo-Filho; Adriano Caldeira-de-Araujo
Journal:  Molecules       Date:  2012-11-01       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.